HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zixiu Xiang Selected Research

N- (3- oxo- 3- (4- (pyridin- 4- yl)piperazin- 1- yl)propyl)benzo(c)(1,2,5)thiadiazole- 4- sulfonamide

3/2012Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease.
8/2009A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zixiu Xiang Research Topics

Disease

15Schizophrenia (Dementia Praecox)
01/2021 - 08/2007
6Parkinson Disease (Parkinson's Disease)
01/2016 - 12/2005
5Alzheimer Disease (Alzheimer's Disease)
12/2019 - 10/2008
4Catalepsy
03/2012 - 10/2008
2Central Nervous System Diseases (CNS Diseases)
09/2013 - 01/2008
2Seizures (Absence Seizure)
09/2013 - 08/2009
1Rett Syndrome (Rett's Disorder)
01/2017
1Neurodevelopmental Disorders
01/2017
1Fragile X Syndrome (Martin Bell Syndrome)
01/2016
1Dyskinesias (Dyskinesia)
01/2016
1Bipolar Disorder (Manic Depressive Psychosis)
01/2015
1Dystonia (Limb Dystonia)
08/2009
1Psychotic Disorders (Schizoaffective Disorder)
08/2007
1Glioma (Gliomas)
06/2004
1Infections
06/2004
1Neoplasms (Cancer)
06/2004

Drug/Important Bio-Agent (IBA)

9Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2021 - 08/2007
8Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
12/2019 - 01/2008
3Antipsychotic Agents (Antipsychotics)IBA
09/2016 - 08/2007
3Haloperidol (Haldol)FDA LinkGeneric
03/2012 - 11/2008
2Glutamic Acid (Glutamate)FDA Link
10/2017 - 08/2007
2Cholinergic Agents (Cholinergics)IBA
10/2017 - 09/2016
2N- (3- oxo- 3- (4- (pyridin- 4- yl)piperazin- 1- yl)propyl)benzo(c)(1,2,5)thiadiazole- 4- sulfonamideIBA
03/2012 - 08/2009
2Reserpine (Serpasil)FDA Link
03/2012 - 11/2008
1Phencyclidine (Angel Dust)IBA
10/2017
1Muscarinic M1 ReceptorIBA
10/2017
1Methyl-CpG-Binding Protein 2IBA
01/2017
1Levodopa (L Dopa)FDA LinkGeneric
01/2016
1Therapeutic UsesIBA
01/2016
1Glutamate Receptors (Glutamate Receptor)IBA
05/2015
1N-Methylaspartate (NMDA)IBA
05/2015
1metabotropic glutamate receptor 3 (mGluR3)IBA
01/2015
1Metabotropic Glutamate 5 ReceptorIBA
10/2013
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
09/2013
1Scopolamine (Hyoscine)FDA Link
03/2012
1T-Type Calcium Channels (T-Type Calcium Channel)IBA
12/2011
1Pilocarpine (Ocusert)FDA LinkGeneric
08/2009
1VU 0155041IBA
11/2008
1Hallucinogens (Psychedelics)IBA
08/2007
1Dopamine (Intropin)FDA LinkGeneric
12/2005
1Interferon-betaIBA
06/2004
1Glycoproteins (Glycoprotein)IBA
06/2004
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
06/2004

Therapy/Procedure

1Therapeutics
06/2004